ArticlePloS one2026
A chemically optimized, GalNAc-conjugated siRNA targeting HSD17B13 demonstrates efficacy in a human 3D organoid model of MASH, showcasing an alternative to animal testing.
Qin Meng et al.PubMed ↗Publisher ↗
No numbers read from the abstract.